People: Protalix Biotherapeutics Inc (PLX.TA)

PLX.TA on Tel Aviv Stock Exchange

725.00
29 Jun 2015
Change (% chg)

-4.00₪ (-0.55%)
Prev Close
732.70₪
Open
717.10₪
Day's High
752.90₪
Day's Low
717.10₪
Volume
110,820
Avg. Vol
112,481
52-wk High
1,300.00₪
52-wk Low
668.80₪

Search Stocks

Lauterbach, Sandra 

Ms. Sandra L. Lauterbach is Vice President - Sales and Commercial Affairs of Protalix BioTherapeutics Inc., since December 18, 2009. Prior to joining the company, Ms. Lauterbach was the Vice President of Marketing, Endocrinology of EMD Serono, Inc., from July 2008 through July 2009. Prior to that, from August 2003 through July 2008, she served in a number of positions at Genzyme Corporation, the last position being the Senior Director, Global Marketing of Fabrazyme. Ms. Lauterbach holds a B.Sc. in Molecular Biology from the University of Wisconsin—Madison and an MBA from the University of South Florida.

Basic Compensation

Total Annual Compensation, USD 186,410
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 467,810
Fiscal Year Total, USD 654,220

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Shlomo Yanai

--

Moshe Manor

--

Yossi Maimon

1,389,600

Tzvi Palash

669,029

Yoseph Shaaltiel

1,594,580

Einat Almon

1,436,370
As Of  30 Dec 2012
Search Stocks